Adverse effects of cyclophosphamide on progeny outcome can be mediated through post-testicular mechanisms in the rat

• Published in: Biology of reproduction Vol. 46; no. 5; p. 926
• Main Authors: Qiu, J, Hales, B F, Robaire, B
• Format: Journal Article
• Language: English
• Published: United States Society for the Study of Reproduction 01.05.1992
• Subjects: Animals; Cyclophosphamide - administration & dosage; Cyclophosphamide - toxicity; Epididymis - drug effects; Female; Fetal Death - chemically induced; Fetus - drug effects; Male; Pregnancy; Pregnancy Outcome; Rats; Rats, Inbred Strains; Spermatozoa - drug effects; Testis - drug effects
• ISSN: 0006-3363; 1529-7268
• DOI: 10.1095/biolreprod46.5.926

Previous studies from our laboratory have suggested that, in addition to an effect on spermatozoa in the testis, cyclophosphamide may have an adverse effect on spermatozoa after they leave the testis, during epididymal transit. To elaborate on this post-testicular effect on germ cells and to determine at which site(s) in the epididymis germ cells are most sensitive to cyclophosphamide treatment, three experiments were undertaken. First, the time course of the effect of treatment of male rats with cyclophosphamide on the outcome of their progeny was determined. Male rats were treated daily by gavage with saline or one of two doses of cyclophosphamide (6.8 mg/kg or 10.0 mg/kg) for 1, 4, or 7 days. At the end of each treatment period, males were mated to assess the effect on pregnancy outcome. No effect was observed on pre-implantation loss at any time among any of the groups, but there was a time-dependent and dose-related increase in post-implantation loss. Post-implantation loss was significantly increased after 4 days of treatment and reached nearly 40% after 7 days of drug exposure (10.0 mg/kg). Second, the effect of treatment with single high doses of cyclophosphamide was studied. Male rats were treated with a single dose of cyclophosphamide (10, 30, or 70 mg/kg) and bred 1 day and 4 days post-treatment. No significant change in pre-implantation loss was observed at either time point; no change in post-implantation loss was found after 1 day post-treatment. However, a significant increase in post-implantation loss was observed in the two high-dose groups 4 days post-treatment.